Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.
Par Pharmaceutical Cos. has bought rights to a generic version of a drug used to treat bipolar disorder and schizophrenia.
A federal court has dismissed a case that drug maker AstraZeneca filed against regulators regarding a drug used to treat psychotic and bipolar disorders, the company said Monday.
Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.
Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.